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Essential Thrombocythemia Associated with Plasma Cell
Neoplasm
M. Eltahir1, A. Barbieri1, G. Rivero2; 1Department
of Pathology and Immunology, Baylor College of
Medicine, Houston, Texas, United States, 2Department of
Hematology and Oncology, Baylor College of Medicine,
Houston, Texas, United States
Introduction/Objective: The co-occurrence of essential
thrombocythemia (ET) and multiple myeloma (MM),
two distinct entities with distinct cellular origin, is rare,
with a limited number of cases reported.
Methods/Case Report: We report a case of a 63-year-old
male who initially presented with thrombocytosis, splenomegaly and elevated LDH. A bone marrow examination
showed hypercellularity (90%) with increased abnormal
megakaryocytes, as well as a JAK2 V617F mutation,
with overall features consistent with involvement by a
myeloproliferative neoplasm (MPN), consistent with ET
(versus early primary myelofibrosis (PMF)). Additionally,
6% kappa-restricted plasma cells were identified, consistent with involvement by a monoclonal gammopathy of
undetermined significance (MGUS). The patient was subsequently treated with hydroxyurea. Four years later, he
presented with evidence of paraproteinemia. IgG kappa
monoclonal paraprotein was elevated at 3.4 g/dL. A repeat
bone marrow examination showed hyper-cellularity (60%),
including clusters of abnormal megakaryocytes and mild
to moderate reticulin fibrosis. The previously identified
kappa-restricted plasma cell population increased to approximately 40% of the total cellularity. Cytogenetic analysis showed a normal male karyotype (46,XY[20]), and
a prognostic myeloma-FISH panel including 13q-/-13,
1q32/1q21, p53/NF1, CCND1/IgH t(11;14), FGFR3/IgH
t(4;14), IgH/MAF t(14;16) and IgH/MAFB t(14;20) was
negative for all tested abnormalities. The overall features
were again consistent with involvement by an MPN and
progression of the previously identified MGUS.
Results (if a Case Study enter NA): NA.
Conclusion: Only a few cases of concurrent ET and
MM have been previously reported in the literature, with
most of these cases having a temporal association with
alkylating agent therapy. However, MM development
has also been reported in a patient with non-cytotoxic
treatment of ET. In contrast, our patient was diagnosed
with ET associated with MGUS at the initial diagnosis.
Notably, the co-existence of early PMF with MM appears
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to be relatively more established. A large study showed
that previous PMF was strongly associated with MM development (OR 24.3; 95% CI:2.9-201.5).

Focal Myositis with CD8+T-Cell predominance: an
Inflammatory Myositis Mimicking a Soft Tissue
Neoplasm
M. Shaheen, L. Warmke, M. Nassiri; Pathology and
Laboratory Medicine, Indiana University, Indianapolis,
Indiana, United States
Introduction/Objective: FM is a rare self-limiting T-cell rich
lesion arising within muscles of young adults as a solitary
lesion and can be confused with a variety of neoplastic/
inflammatory conditions or lymphoma. Here we describe
a rare T-cell rich variant of FM with CD8 predominance.
Methods/Case Report: A 51-year-old female presented
with two-month history of left trapezius swelling. MRI
showed an enhancing tumor within the muscle, suspicious
of sarcoma, less likely myeloma.
Results (if a Case Study enter NA): Biopsy showed diffuse infiltration of small lymphocytes in a fibrotic background and atrophic skeletal muscle. These lymphocytes
stained positive for CD2, CD3, CD7, CD8, CD5 (partial), TIA1 (partial), CD43, CD57 and negative for CD4,
CD30, CD56, CD57, granzyme B, perforin, BCL-6, BCL2, Pax5, TCL1, and CD56. Ki-67 was (<10%) with few
background CD20+ B cells. By flow cytometry, the CD8+
T-cells co-express CD2, CD3, CD7, with dim CD5 expression. TCR gene rearrangement study by PCR showed
no clonal TCR Gamma gene rearrangement.
Conclusion: FM is extremely rare with only 22 cases welldescribed in the literature, all predominantly composed
of CD4+ T-cells, clinically concerning for low-grade
sarcomas, as inflammatory myofibroblastic tumor, inflammatory leiomyosarcoma, or liposarcoma. Careful analysis
is essential for correct diagnosis. Mimics include other
causes of myositis, such as polymyositis and inclusion
body myositis. Depending on the extent of lymphocytic
infiltrate, gene rearrangement studies might be necessary
to rule out clonality. Recognition of this rare entity with
excellent prognosis is crucial to provide appropriate management and avoid unnecessary, aggressive procedures.

A Unusual Case of Classic Hodgkin Lymphoma (cHL)
with Aberrant T-Antigens Expression
S. Gaddam, O. Oyedeji, W. liu, J.C. Gomez-Gelvez,
K. Inamdar, J. Carey, Y. Shen; Pathology, Henry Ford
Hospital, Detroit, Michigan, United States
Introduction/Objective: T-cell-associated antigens (TCA)
are rarely expressed by Hodgkin/Reed-Sternberg (HRS)
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the most common non-recommended indication. The majority of these studies were ordered by the hematology/oncology service, with only a third coming from others. Some
possible causes for these inappropriate requests include ordering studies as a battery instead of a step-wise approach,
and concern for missing an incipient/occult condition.
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Intracranial Extramedullary Hematopoiesis: a Rare Entity
D. Morrar, S. Sham, R. Al-Refai, M. Harshan; Pathology,
Lenox Hill Hospital, New York, New York, United States
Introduction/Objective: Extramedullary
hematopoiesis
(EMH) is characterized by ectopic proliferation and differentiation of hematopoietic precursor cells outside the bone
marrow. In postnatal life, EMH occurs due to hematopoietic disorders, infection or advanced tumors and is usually
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seen in the spleen, liver, and lymph nodes. Intracranial
EMH is an extremely rare entity that has been reported to
be associated with hematological disorders, meningioma,
subdural hematoma and pilocytic astrocytoma.
Methods/Case Report: To highlight the significance of
identifying EMH as one of the differential diagnoses
of brain lesions, we present a 67-year-old female with a
history of headaches and generalized malaise. Her past
medical history was significant for hypertension and
mild anemia. As part of the headache workup, magnetic resonance imaging (MRI) of the brain showed
a 3.7cm cystic mass in the right inferomedial parietal
lobe with medial mural enhancement, associated with
edema and mass effect. A similar 3mm left parietal lobe
enhancing focus was also noted. These findings were suggestive of a hemangioblastoma. Resection of the larger
mass showed a benign vascular lesion with endothelial
hyperplasia without the appearance of cavernous hemangioma or vascular malformation. Foci of erythroid
and myeloid precursors, and megakaryocytes were seen.
Immunohistochemical stains were negative for GFAP, CK
AE1/AE3 and inhibin ruling out glial neoplasms, metastatic carcinoma and hemangioblastoma. Hematopoietic
cells were positive for CD45, while immature red cells
were positive for E-cadherin and endothelial cells were
positive for CD31, consistent with EMH. Further
workup was negative for any underlying hematological
disorders, resulting in the diagnosis of idiopathic intracranial EMH. The patient received intensity- modulated
radiation therapy (IMRT) for her remaining left parietal
lesion. After 3 months of regular follow-up, her headache
and malaise significantly improved.
Results (if a Case Study enter NA): NA.
Conclusion: To our knowledge, this is the first reported
case of idiopathic intracranial EMH.

Immunoglobulin G4-Related Disease (IgG4-RD)
Mimicking Hyaline Vascular Castleman Disease
S.S. Karimi1, S. Fidai2; 1Pathology, University of Illinois
Chicago, Chicago, Illinois, United States, 2Pathology,
Cook County Hospital, Chicago, Illinois, United States
Introduction/Objective: Immunoglobulin G4-related disease (IgG4-RD) is a newly emerging immune-mediated
fibroinflammatory disease characterized by increased
IgG-4+ plasma cells. In soft tissue and visceral organs,
the IgG4+ plasma cells often accompany a storiform pattern of fibrosis with obliterative phlebitis. In lymph nodes,
rare cases have been described in the literature mimicking
Multicentric Castleman Disease.
Methods/Case Report: Herein, we present a case of a
59-year-old male with history of lung adenocarcinoma
status post resection one year prior, who presented with
several months of unintentional weight loss and worsening
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cells of classical Hodgkin lymphoma (cHL) and is associated with uncertain clinical significance.
Methods/Case Report: We present a very recent case of
a 68 year-old female with no significant past medical history presented with a large right groin mass for 1 month.
She denied any fever, night sweats, fatigue or weight loss.
CT abdomen/pelvis showed inguinal/pelvic lymphadenopathy. Resection showed effaced nodal architecture
with a vague nodular appearance and with large, atypical
nucleolated cells in a background of small, mature lymphocytes and histiocytes. Eosinophils are conspicuously absent in the background. The large cells were polylobated
lymphocyte and histiocyte rich (L & H) like, classic HRS
cells as well as multinucleated in appearance. The morphologic features overlapped between Classic Hodgkin
Lymphoma, and Nodular Lymphocyte Predominant
Hodgkin Lymphoma. Given the immunohistochemical
(IHC) features of the neoplastic cells [CD45 negative,
PAX5+ (weak), CD30+ (strong), CD15+ (majority) and
MUM1 +] the diagnosis was most compatible with CHL.
Interestingly, a subset of the Hodgkin cells (10-20%) aberrantly expressed a number of T-cell markers (CD2, CD3,
CD4, and CD8). However, the background smaller T-cells
did not show cytologic atypia or aberrancies of T-cell antigen markers. The large cells were negative for CD43 and
ALK1. TCR gamma gene rearrangement was also negative for clonal T-lymphocytes, thus excluding the possibility of peripheral T-cell lymphoma with Hodgkin-like
cells. Based on the morphology and IHC profile, this case
proves to be CHL with multiple TCA expression including
CD2, CD3, CD4 and CD8. She was planned for chemotherapy. Four months after the initial diagnosis and after
completion of 2 cycles of chemotherapy, her PET CT
scan showed improvement with right inguinal adenopathy
being smaller in size and decreased avidity, indicating a
response to treatment. She is due for 2 more cycles. Till
todate she is doing well with no further symptoms.
Results (if a Case Study enter NA): NA.
Conclusion: So far reported cases of classic Hodgkin lymphoma (CHL) with aberrant T-cell antigen (TCA) expression were associated with decreased event-free survival
and overall survival when compared with TCA-negative
CHLs. Our finding contributes to the literature and improves our knowledge of the disease.

